46.46.Z - Wholesale of pharmaceutical goods
10 - Manufacture of food products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
70 - Activities of head offices; management consultancy activities
73 - Advertising and market research
77 - Rental and leasing activities
96 - Other personal service activities
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,2 | 0,3 | -0,3 | -187,3 |
EBITDA | 0,2 | 0,4 | -0,1 | -138,3 |
Short time liabilities | 0,4 | 0,4 | 1,5 | 256,9 |
Equity capital | 0,3 | 1,1 | 0,7 | -32,4 |
Operating profit (EBIT) | 0,2 | 0,3 | -0,2 | -150,6 |
Assets | 0,7 | 2,7 | 3,7 | 37 |
Net profit (loss) | 0,2 | 0,3 | -0,3 | -187,3 |
Cash | 0,2 | 0,1 | 0,1 | 36,1 |
Net income from sale | 1,3 | 1,9 | 3 | 57,1 |
Liabilities and provisions for liabilities | 0,4 | 1,6 | 3 | 81,4 |
Working assets | 0,6 | 2,7 | 1,6 | -38,2 |
Depreciation | 0 | 0 | 0 | 296,9 |
% | % | % | p.p. | |
Profitability of capital | 54,4 | 33,1 | -42,8 | -75,9 |
Equity capital to total assets | 45,5 | 39 | 19,2 | -19,8 |
Gross profit margin | 12,4 | 17,9 | -10 | -27,9 |
EBITDA Margin | 13,3 | 18,2 | -4,4 | -22,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 99 | 80 | 182 | 102 |
Current financial liquidity indicator | 1.7359570264816284 | 1.6224958896636963 | 1.0835274457931519 | -0,5 |
Net dept to EBITDA | -1.071845531463623 | -0.17983873188495636 | -13.160879135131836 | -13 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane